Stay updated on Foralumab Safety in NASH and T2DM Clinical Trial
Sign up to get notified when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.

Latest updates to the Foralumab Safety in NASH and T2DM Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry for v3.6.2 was added to the record history, and the older revision v3.6.0 was removed from the history list.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision v3.6.0 was added to the study record history. An older revision v3.5.5 was removed from the history.SummaryDifference0.6%

- Check22 days agoChange DetectedA new revision entry, Revision: v3.5.5, was added to the study record history, replacing the previous Revision: v3.5.4. This indicates an update to the record's documentation.SummaryDifference0.1%

- Check43 days agoChange DetectedA new revision entry (v3.5.4) is added to the study record history, replacing the previous v3.5.3 to reflect an update in the page's revision history.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page footer/UI now reflects a newer site build revision (v3.5.3 instead of v3.5.2) without changing the displayed clinical trial history details.SummaryDifference0.1%

- Check72 days agoChange DetectedAdded revision v3.5.2 to the study record history and removed revision v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Foralumab Safety in NASH and T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.